You are here

Xcovery

Xcovery wins FDA approval for ALK inhibitor in NSCLC

First Word Pharma

Thu, 12/19/24 - 09:18 pm

non-small cell lung cancer

The Daily Start-Up: Xcovery Secures More Than $6M Series B to Advance Two Drug Candidates, Develop Others

WSJ Online

Tue, 09/18/12 - 11:52 am